Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccinations

Vaccinations

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oseltamivir drug-disease modelling in infants with influenza virus infection.

British journal of clinical pharmacology·2026

Same author

Temperature-Dependent Viral Pathogenicity: Implications for Attenuation of Viral Vaccines.

Viruses·2026

Same author

Modeling Influenza Antiviral Strategies: Reducing Burden and Preventing Resistance.

The Journal of infectious diseases·2025

Same author

Ganciclovir Dosing in Premature Infants Receiving Treatment for Congenital Cytomegalovirus Infection: Results of a Prospective Pharmacokinetic Study.

The Journal of infectious diseases·2025

Same author

Valacyclovir Pharmacokinetics in Infants With Neonatal Herpes Simplex Virus Disease.

The Pediatric infectious disease journal·2025

Same author

Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.

NPJ vaccines·2025

Same journal

NET-inducing ability of Cutibacterium acnes clinical isolates is associated with pathogenicity in acne vulgaris.

The Journal of infectious diseases·2026

Same journal

Optimizing the Use of Proviral DNA HIV Drug Resistance Testing: Clinical Applications and Cautions.

The Journal of infectious diseases·2026

Same journal

Monitoring HLA-A2-restricted T cell responses and BCLA-specific serostatus during human latent Toxoplasma gondii infection suggests the implication of CD8+ T cells in parasite containment.

The Journal of infectious diseases·2026

Same journal

Cryptosporidiosis in Ptients with Inborn Errors of Immunity: Retrospective cohort study of the French National Reference Center (CEREDIH).

The Journal of infectious diseases·2026

Same journal

Type 3 fimbrial regulation underpins anti-MrkA immunotherapeutic efficacy in experimental Klebsiella pneumoniae infection.

The Journal of infectious diseases·2026

Same journal

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 14, 2026

Influenza A Virus Studies in a Mouse Model of Infection

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Introduction and Update: Advances in Influenza Therapeutics.

Frederick G Hayden¹, Richard J Whitley²

¹Division of Infectious Diseases and International Health, Department of Medicine, School of Medicine, University of Virginia, Charlottesville, Virginia.

The Journal of Infectious Diseases

|October 16, 2025

Summary

This summary is machine-generated.

This collection reviews advances in influenza therapeutics and strategies for prevention and treatment. It identifies current limitations and future research needs for seasonal, zoonotic, and pandemic influenza.

Area of Science:

Virology
Infectious Diseases
Public Health

Background:

Keywords:

Influenza antibodies antiviral resistance antivirals clinical trials diagnostic testing immunomodulators pandemic prevention treatment zoonotic influenza

More Related Videos

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Related Experiment Videos

Last Updated: Jan 14, 2026

Influenza A Virus Studies in a Mouse Model of Infection

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Influenza poses a significant global health threat, necessitating continuous advancements in treatment and prevention.

Current influenza therapeutics face challenges including resistance and limited efficacy against diverse strains.

Strategies for diagnostics, rapid access, and resistance monitoring are crucial for effective influenza control.